Literature DB >> 6115112

Pathogenesis of subacute combined degeneration: a result of methyl group deficiency.

J M Scott, J J Dinn, P Wilson, D G Weir.   

Abstract

Four pairs of monkeys were maintained in an atmosphere of nitrous oxide under conditions which had previously been shown to produce subacute combined degeneration (SCD) of the spinal cord. The diet of one of each pair was supplemented with methionine. In every case the monkey with the unsupplemented diet became ataxic at around 10 weeks and the disorder progressed over a period of 2-3 weeks until the animal was moribund. During this period there was no detectable clinical change in the monkeys receiving methionine supplementation. Microscopical examination of the spinal cord and peripheral nerves of the unsupplemented monkeys showed the classical changes of SCD. The histological changes correlated with the clinical observations. Sections form the methionine-supplemented monkeys showed no change or only slight changes. These results suggest that, in these animals, inability to resynthesise methionine from homocysteine leads to SCD. It seems probable that the primary lesion producing SCD in human beings with pernicious anaemia is also inability to maintain methionine biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115112     DOI: 10.1016/s0140-6736(81)90649-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  38 in total

Review 1.  Benefits and risks of folic acid to the nervous system.

Authors:  E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

Review 2.  Cobalamin and folate: recent developments.

Authors:  I Chanarin; R Deacon; M Lumb; J Perry
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

Review 3.  Cellular and molecular aspects of myelin protein gene expression.

Authors:  A T Campagnoni; W B Macklin
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

4.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

Review 5.  Adverse effects of nitrous oxide.

Authors:  J B Brodsky; E N Cohen
Journal:  Med Toxicol       Date:  1986 Sep-Oct

6.  Subacute combined degeneration of the cord due to folate deficiency: response to methyl folate treatment.

Authors:  E G Lever; R D Elwes; A Williams; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

Review 7.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

8.  Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone.

Authors:  S T Frequin; R A Wevers; M Braam; F Barkhof; O R Hommes
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

Review 9.  Mouse models to elucidate mechanisms of folate-related cancer pathologies.

Authors:  Patrick J Stover; Amanda J MacFarlane
Journal:  Nutr Rev       Date:  2008-08       Impact factor: 7.110

10.  Neurological involvement in hereditary transcobalamin II deficiency.

Authors:  P K Thomas; A V Hoffbrand; I S Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.